Oesophageal adenocarcinoma or gastric cancer with or without eradication of Helicobacter pylori infection in chronic atrophic gastritis patients: A hypothetical opinion from a systematic review

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 20, Issue 1, 2004, Pages 54-61

  Nakajima, S ^a,b,c   Hattori, T ^b  

^a Shiga Hospital of Social Insurance   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c Social Insurance Shiga Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPHIC GASTRITIS; BARRETT ESOPHAGUS; CANCER INCIDENCE; CANCER RISK; CONFERENCE PAPER; ERADICATION THERAPY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CANCER; HELICOBACTER INFECTION; HUMAN; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; STOMACH CANCER; SYSTEMATIC REVIEW;

EID: 4344563512     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2004.01975.x     Document Type: Conference Paper

References (30)

1. Nakajima S, Graham DY, Hattori T, Bamba T. Strategy for treatment of Helicobacter pylori infection in adults. I. Updated indications for test and eradication therapy suggested in 2000. Curr Pharm Des 2000; 6: 1503-14.
2. Nakajima S, Graham DY, Hattori T, Bamba T. Strategy for treatment of Helicobacter pylori infection in adults. II. Practical policy in 2000. Curr Pharm Des 2000; 6: 1515-29.
3. Labenz J, Blum AL, Bayerdörffer E, Meining A, Stolte M, Börsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997; 112: 1442-7.
4. Nakajima S, Hattori T. Active and inactive gastroesophageal reflux diseases related to Helicobacter pylori therapy. Helicobacter 2003; 8: 279-93.
5. Cameron AJ. Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol Clin North Am 1997; 26: 487-94.
6. Xia HH, Talley NJ. Helicobacter pylori infection, reflux esophagitis, and atrophic gastritis: an unexplored triangle. Am J Gastroenterol 1998; 93: 394-400.
7. Correa P. Human gastric carcinogenesis. a multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 15: 6735-40.
8. Uemura N, Mukai T, Okamoto S, et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 1997; 6: 639-42.
9. Hamada H, Haruma K, Mihara M, et al. High incidence of reflux esophagitis after eradication therapy for Helicobacter pylori: impacts of hiatus hernia and corpus gastritis. Aliment Pharmacol Ther 2000; 14: 729-35.
10. Anand BS, Graham DY. Ulcer and gastritis. Endoscopy 1999; 31: 215-25.
11. Schütze K, Hentschel E, Dragosics B, Hirschl AM. Helicobacter pylori reinfection with identical organisms: transmission by the patients' spouses. Gut 1995; 36: 831-3.
12. Hirota WK, Loughney TM, Lazas DJ, Maydonovitch CL, Rholl V, Wong RKH. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 1999; 116: 277-85.
13. Weston AP, Krmpotich P, Makdisi WF, et al. Short segment Barrett's esophagus: clinical and histological features, associated endoscopic findings, and association with gastric intestinal metaplasia. Am J Gastroenterol 1996; 91: 981-6.
14. Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, Eskes SA, Meuwissen SG. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease. Am J Gastroenterol 1999; 94: 884-7.
15. Weston AP, Badr AS, Topalovski M, Cherian R, Dixon A, Hassanein RS. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma. Am J Gastroienterol 2000; 95: 387-94.
16. Yachida S, Saito D, Kozu T, et al. Endoscopically demonstrable esophageal changes after Helicobacter pylori eradication in patients with gastric disease. J Gastroenterol Hepatol 2001; 16: 1346-52.
17. Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 2000; 119: 333-8.
18. Spechler SJ. Barrett's esophagus: an overrated cancer risk factor. Gastroenterology 2000; 119: 587-9.
19. Tytgat GNJ. Does endoscopic surveillance in esophageal columnar metaplasia (Barrett's esophagus) have any real value? Endoscopy 1995; 27: 19-26.
20. Van der Burgh A, Dees J, Hop WCJ, van Blankenstein M. Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. Gut 1996; 39: 5-8.
21. Moghissi K, Sharpe DA, Pender D. Adenocarcinoma and Barrett's oesophagus. A clinico-pathological study. Eur J Cardiothorac Surg 1993; 7: 126-31.
22. Winters C Jr, Spurling TJ, Chobanian SJ, et al. Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 1987; 92: 118-24.
23. Cameron AJ, Lomboy CT. Barrett's esophagus: age, prevalence, and extent of columnar epithelium. Gastroenterology 1992; 103: 1241-5.
24. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-9.
25. O'Connor JB, Falk GW, Richter JE. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's esophagus registry. Am J Gastroenterol 1999; 94: 2037-42.
26. McDonald ML, Trastek VF, Allen MS, Deschamps C, Pairolero PC. Barrett's esophagus: does an antireflux procedure reduce the need for endoscopic surveillance? J Thorc Cardiovasc Surg 1996; 111: 1135-8.
27. Loffeld RJ, Werdmuller BF, Kuster JG, Perez-Perez GI, Blaser MJ, Kuipers EJ. Colonization with cagA-positive Helicobacter pylori strains inversely associated with reflux esophagitis and Barrett's esophagus. Digestion 2000; 62: 95-9.
28. Klinkenberg-Knol EC, Nelis F, Dent J, et al. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. Gastroenterology 2000; 118: 661-9.
29. Schwaitzberg SD, et al. Surgical management of gastroesophageal reflux. UpToDate 2004, UpToDate Inc., Wellesley, MA, USA; www.uptodate.com. Available at: http://www.uptodate.com.
30. Nostrant TT, Rabine MJ. Endoscopic treatment for gastroesophageal reflux disease. Curr Treat Options Gastroenterol 2002; 5: 51-61.